Opioid substitution with methadone and buprenorphine: Sexual dysfunction as a side effect of therapy

Heroin Addiction and Related Clinical Problems

Volumn 9, Issue 1, 2007, Pages 35-44

  Brown, Randall T ^a,b   Zueldorff, Megan ^a  

^a UNIVERSITY OF WISCONSIN   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Buprenorphine; Methadone; Opioid replacement therapy; Sexual dysfunction

Indexed keywords

ACETYLMETHADOL; ANTIHYPERTENSIVE AGENT; BROMOCRIPTINE; BUPRENORPHINE; FOLLITROPIN; LUTEINIZING HORMONE; METHADONE; OPIATE; PROLACTIN; PSYCHOTROPIC AGENT; TESTOSTERONE;

DOSE RESPONSE; DRUG DOSE REDUCTION; ERECTILE DYSFUNCTION; FEMALE GENITAL SYSTEM; FOLLITROPIN BLOOD LEVEL; HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; LIBIDO DISORDER; LUTEINIZING HORMONE BLOOD LEVEL; MAINTENANCE THERAPY; MALE GENITAL SYSTEM; OPIATE ADDICTION; ORGASM DISORDER; PREVALENCE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PSYCHOLOGICAL ASPECT; REPRODUCTION; REVIEW; SEXUAL DYSFUNCTION; SIDE EFFECT; TESTOSTERONE BLOOD LEVEL; TREATMENT DURATION;

EID: 40549103457     PISSN: 15921638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Abel, E. L. (1984): Opiates and sex. J. Psychoactive Drugs 16: 205-16.
2. Araujo, A. B., Johannes, C. B., Feldman, H. A., Derby, C. A. and McKinlay, J. B. (2000): Relation between psychosocial risk factors and incident erectile dysfunction: prospective results from the Massachusetts Male Aging Study. Am. J. Epidemiol. 152: 533-41.
3. Arlt, W. (2006): Androgen therapy in women. Eur. J. Endocrinol. 154: 1-11.
4. Bancroft, J. (2005): The endocrinology of sexual arousal. J. Endocrinol. 186: 411-27.
5. Bliesener, N., Albrecht, S., Schwager, A., Weckbecker, K., Lichtermann, D. and Klingmuller, D. (2005): Plasma testosterone and sexual function in men receiving buprenorphine maintenance for opioid dependence. J. Clin. Endocrinol. Metab. 90: 203-6.
6. Brambilla, F., Sacchetti, E. and Brunetta, M. (1977): Pituitary-gonadal function in heroin addicts. Neuropsychobiology 3: 160-6.
7. Braunstein, G. D., Sundwall, D. A., Katz, M., Shifren, J. L., Buster, J. E., Simon, J. A., Bachman, G., Aguirre, O. A., Lucas, J. D., Rodenberg, C., Buch, A. and Watts, N. B. (2005): Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial. Arch. Intern. Med. 165: 1582-9.
8. Brown, R., Balousek, S., Mundt, M. and Fleming, M. (2005): Methadone maintenance and male sexual dysfunction. J. Addict. Dis. 24: 91-106.
9. Cicero, T. J., Bell, R. D., Wiest, W. G., Allison, J. H., Polakoski, K. and Robins, E. (1975): Function of the male sex organs in heroin and methadone users. N. Engl. J. Med. 292: 882-7.
10. Cicero, T. J., Meyer, E. R., Bell, R. D. and Koch, G. A. (1976): Effects of morphine and methadone on serum testosterone and luteinizing hormone levels and on the secondary sex organs of the male rat. Endocrinology 98: 367-72.
11. Cofrancesco, J., Shah, N., Ghanem, K. G., Dobs, A. S., Klein, R. S., Mayer, K., Schuman, P., Vlahov, D. and Rompalo, A. M. (2006): The effects of illicit drug use and HIV infection on sex hormone levels in women. Gynecol. Endocrinol. 22: 244-51.
12. Cushman, P. (1972): Sexual behavior in heroin addiction and methadone maintenance. N. Y. State J. Med. 72: 1261-5.
13. Cushman, P., Jr. and Kreek, M. J. (1974): Methadone-maintained patients. Effect of methadone on plasma testosterone, FSH, LH, and prolactin. N. Y. State J. Med. 74: 1970-3.
14. Daniell, H. W. (2002): Narcotic-induced hypogonadism during therapy for heroin addiction. J. Addict. Dis. 21: 47-53.
15. Daniell, H. W., Lentz, R. and Mazer, N. A. (2006): Open-label pilot study of testosterone patch therapy in men with opioid-induced androgen deficiency. J Pain 7: 200-10.
16. Deglon, J. M., JL and Imer, R. (2004): Methadone patients' sexual dysfunctions: Clinical and treatment issues. Heroin Addiction and Related Clinical Problems 6: 17-26.
17. Dyer, K. R. and White, J. M. (1997): Patterns of symptom complaints in methadone maintenance patients. Addiction 92: 1445-55.
18. EMCDDA. (2003): In European Monitoring Center for Drugs and Drug Addiction, Annual Report 2006: The State of the Drugs Problem in Europe.
19. Feldman, H. A., Goldstein, I., Hatzichristou, D. G., Krane, R. J. and McKinlay, J. B. (1994): Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J. Urol. 151: 54-61.
20. Hanbury, R., Cohen, M. and Stimmel, B. (1977): Adequacy of sexual performance in men maintained on methadone. Am J Drug Alcohol Abuse 4: 13-20.
21. Kandeel, F. R., Koussa, V. K. and Swerdloff, R. S. (2001): Male sexual function and its disorders: physiology, pathophysiology, clinical investigation, and treatment. Endocr. Rev. 22: 342-88.
22. Koutouvidis, N., Pratikakis, M. and Fotiadou, A. (1999): The use of mirtazapine in a group of 11 patients following poor compliance to selective serotonin reuptake inhibitor treatment due to sexual dysfunction. Int. Clin. Psychopharmacol. 14: 253-5.
23. Kreek, M. (1973): Medical safety and side effects of methadone in tolerant individuals. JAMA 223: 665-668.
24. Mendelson, J. H., Inturrisi, C. E., Renault, P. and Senay, E. C. (1976): Effects of acetylmethadol on plasma testosterone. Clin. Pharmacol. Ther. 19: 371-4.
25. Mendelson, J. H. and Mello, N. K. (1975): Plasma testosterone levels during chronic heroin use and protracted astinence. A study of Hong Kong addicts. Clin. Pharmacol. Ther. 17: 529-33.
26. Mendelson, J. H., Meyer, R. E., Ellingboe, J., Mirin, S. M. and McDougle, M. (1975): Effects of heroin and methadone on plasma cortisol and testosterone. J. Pharmacol. Exp. Ther. 195: 296-302.
27. Ragni, G., De Lauretis, L., Bestetti, O., Sghedoni, D. and Gambaro, V. (1988): Gonadal function in male heroin and methadone addicts. Int J Androl 11: 93-100.
28. Ragni, G., De Lauretis, L., Gambaro, V., Di Pietro, R., Bestetti, O., Recalcati, F. and Papetti, C. (1985): Semen evaluation in heroin and methadone addicts. Acta Eur Fertil 16: 245-9.
29. Rosen, M. P., Greenfield, A. J., Walker, T. G., Grant, P., Dubrow, J., Bettmann, M. A., Fried, L. E. and Goldstein, I. (1991): Cigarette smoking: an independent risk factor for atherosclerosis in the hypogastric-cavernous arterial bed of men with arteriogenic impotence. J. Urol. 145: 759-63.
30. Rosen, R. C. (1997): Sexual dysfunction as an obstacle to compliance with antihypertensive therapy. Blood Press. Suppl. 1: 47-51.
31. SAMHSA. (2004): In National Survey of Substance Abuse Treatment Services (N-SSATS): 2004 Data on Substance Abuse Treatment Facilities.
32. Sbrocco, T., Weisberg, R. B., Barlow, D. H. and Carter, M. M. (1997): The conceptual relationship between panic disorder and male erectile dysfunction. J. Sex Marital Ther. 23: 212-20.
33. Schmittner, J., Schroeder, J. R., Epstein, D. H. and Preston, K. L. (2005): Menstrual cycle length during methadone maintenance. Addiction 100: 829-36.
34. Shinderman, M. and Maxwell, S. (2000): Sexual dysfunction associated with methadone maintenance: Treatment with bromocryptine. Heroin Addiction and Related Clinical Problems 2: 9-14.
35. Spring, W. D., Jr., Willenbring, M. L. and Maddux, T. L. (1992): Sexual dysfunction and psychological distress in methadone maintenance. Int J Addict 27: 1325-34.
36. Teusch, L., Scherbaum, N., Bohme, H., Bender, S., Eschmann-Mehl, G. and Gastpar, M. (1995): Different patterns of sexual dysfunctions associated with psychiatric disorders and psychopharmacological treatment. Results of an investigation by semistructured interview of schizophrenic and neurotic patients and methadonesubstituted opiate addicts. Pharmacopsychiatry 28: 84-92.
37. Trotta, M. P., Ammassari, A., Cozzi-Lepri, A., Zaccarelli, M., Castelli, F., Narciso, P., Melzi, S., De Luca, A., Monforte, A. D., Antinori, A., Adherence Italian Cohort Naive Antiretrovirals Study, G. and Adherence Spallanzani Study, G. (2003): Adherence to highly active antiretroviral therapy is better in patients receiving non-nucleoside reverse transcriptase inhibitor-containing regimens than in those receiving protease inhibitor-containing regimens. Aids. 17: 1099-102.
38. Tuiten, A., Van Honk, J., Koppeschaar, H., Bernaards, C., Thijssen, J. and Verbaten, R. (2000): Time course of effects of testosterone administration on sexual arousal in women. Arch. Gen. Psychiatry 57: 149-53; discussion 155-6.
39. Willenbring, M. L., Morley, J. E., Krahn, D. D., Carlson, G. A., Levine, A. S. and Shafer, R. B. (1989): Psychoneuroendocrine effects of methadone maintenance. Psychoneuroendocrinology 14: 371-91.